Skip to content

Procalcitonin Level as a Surrogate for Catheter-related Blood Stream Bacteremia Among Hemodialysis Patients

Procalcitonin Level as a Surrogate for Catheter-related Blood Stream Bacteremia Among Hemodialysis Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03039777
Enrollment
28
Registered
2017-02-01
Start date
2016-09-01
Completion date
2017-03-01
Last updated
2017-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodialysis Catheter Infection

Brief summary

Hemodialysis patients frequently develop catheter-related blood stream bacteremia (CRBSI). Procalcitonin is a marker of sepsis in bacterial infection. this study for detection of its role as a surrogacy marker in CRBSI.

Detailed description

Catheter-related blood stream bacteremia is common among hemodialysis patients. Clinically, fever and/or rigors with laboratory indicator of inflammation as leucocytosis and elevated c-reactive protein level are considered as markers for CRBSI before blood culture results became available. Procalcitonin is a valid indicator of sepsis. In this study, Procalcitonin level will be measured in any patient with suspected CRBSI and correlation will be tested for proved CRBSI by blood cultures.

Interventions

None listed

Sponsors

New Jeddah Clinic Hospital
CollaboratorINDUSTRY
Benha University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Hemodialysis patients with a dialysis catheter * signs suggestive of CRBSI: fever/chills or leucocytosis with no other site of infection. * Informed consent signed to be enrolled in the study

Exclusion criteria

* Patient with identified cause of fever other than CRBSI

Design outcomes

Primary

MeasureTime frameDescription
Procalcitonin Level2 minutes after start of fever/chills or other symptoms suggesting CRBSILevel of serum procalcitonin

Other

MeasureTime frameDescription
C Reactive Protein2 minutes after start of fever/chills or other symptoms suggesting CRBSILevel of C reactive protein
erythrocyte sedimentation rate2 minutes after start of fever/chills or other symptoms suggesting CRBSIerythrocyte sedimentation rate
Urea Reduction Rateup to 30 days prior to start of fever/chills or other symptoms suggesting CRBSIUrea Reduction rate
creatinineup to 30 days prior to start of fever/chills or other symptoms suggesting CRBSIpredialysis Serum creatinine
Blood culture (central and peripheral) results5 minutes after start of fever/chills or other symptoms suggesting CRBSIBlood cultures organism growth results (positive/negative) confirming CRBSI
Hemoglobinup to 30 days prior to start of fever/chills or other symptoms suggesting CRBSIHemoglobin
potassiumup to 30 days prior to start of fever/chills or other symptoms suggesting CRBSIpredialysis serum potassium
Sodiumup to 30 days prior to start of fever/chills or other symptoms suggesting CRBSIpredialysis serum sodium
ferritinup to 30 days prior to start of fever/chills or other symptoms suggesting CRBSIpredialysis Serum ferritin

Countries

Saudi Arabia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026